机译:通过靶向配体与通用免疫受体的共价结合对基因工程T细胞活性的定量控制。
Department of Pathology and Laboratory Medicine Perelman School of Medicine Center for Cellular Immunotherapies Perelman School of Medicine and Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania 19104 United States;
Department of Pathology and Laboratory Medicine Perelman School of Medicine and Center for Cellular Immunotherapies Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania 19104 United States;
Center for Cellular Immunotherapies Perelman School of Medicine and Department of Systems Pharmacology and Translational Therapeutics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania 19104 United States;
Department of Cancer Biology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania 19104 United States;
Department of Pathology and Laboratory Medicine Perelman School of Medicine Center for Cellular Immunotherapies Perelman School of Medicine and Parker Institute for Cancer Immunotherapy Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania 19104 United States;
Department of Bioengineering University of Pennsylvania Philadelphia Pennsylvania 19104 United States;
Department of Bioengineering University of Pennsylvania Philadelphia Pennsylvania 19104 United States;
机译:腺病毒介导的CD40配体基因工程树突状细胞诱导增强的CD8 | [plus] |细胞毒性T细胞活化和抗肿瘤免疫
机译:质谱鉴定人雌激素受体α上两个相关雌激素配体的共价附着位点。
机译:鉴定抗雌激素雌二醇11β衍生物在人雌激素受体α配体结合域上的共价连接位点。
机译:肿瘤特异性HLA配体靶向可溶性T细胞受体的工程与武装
机译:受体组的QSARome:作用于多个受体的多个配体集的定量构效关系模型。
机译:移植:PD-L1阻断在延迟过继转移T细胞受体基因工程的同种异体CD8 + T细胞后有效恢复了强大的移植物抗白血病作用而没有移植物抗宿主病
机译:腺病毒介导的CD40配体基因工程树突内细胞引发增强的CD8 +细胞毒性T细胞活化和抗肿瘤免疫力